ERBB2 and neoplasm: Patient tumor biopsies were analyzed using IHC for ERBB2 expression. ERBB2 overexpression and amplification were linked with high-grade and high-stage upper-tract urothelial CA (UTUCs) tumors and with tumor progression. Results suggest that ERBB2 is a biomarker for progression in UTUCs.